Acorda Therapeutics, Inc. (NASDAQ:ACOR) Basic Net EPS Stands At $0.26

0

Acorda Therapeutics, Inc. (NASDAQ:ACOR) had an annual basic consolidated EPS of $0.2619 for the period ended 2015-12-31. For the quarter ended 2015-12-31 which was on quarterly basis, the basic consolidated EPS reading was $0.2619.

EPS from continuing operations

Acorda Therapeutics, Inc. (NASDAQ:ACOR) reported $0.2619 as the basic EPS from continuing operations for the annual period ended 2015-12-31. Quarterly basic EPS from continuing operations stood at $0.2619 for the three-month period ended 2015-12-31.

EPS contribution from parent

From its parent company, Acorda Therapeutics, Inc. (NASDAQ:ACOR) received basic EPS of $0.2619 for the annual period ended 2015-12-31. EPS contribution from the parent company was $0.2619 which was on quarterly basis for the period ended 2015-12-31.

Basic net EPS

A basic net EPS of $0.26 was reported by Acorda Therapeutics, Inc. (NASDAQ:ACOR) for the annual period ended 2015-12-31. For the three-month period ended 2015-12-31 which was on a quarterly basis, the company’s basic net EPS stood at $0.26.

Consolidated diluted EPS

For the period ended 2015-12-31, $0.2535 was reported as the annual consolidated diluted EPS reading. Consolidated diluted EPS was $0.2535 for the quarter ended 2015-12-31.

Basic diluted EPS

Diluted EPS reading from continuing operation was $0.2535 which was on annual basis but for the period ended 2015-12-31. From continuing operations, Diluted EPS was $0.2535 for the quarter ended 2015-12-31.

Net diluted EPS

Net diluted EPS reading was $0.25 for the annual period ended 2015-12-31 while the net diluted EPS for the quarterly period ended 2015-12-31 stood at $0.25.

Diluted EPS from parent

Diluted EPS of $0.2535 was received by Acorda Therapeutics, Inc. (NASDAQ:ACOR) from its parent company which was for the annual period ended 2015-12-31. For the quarter ended 2015-12-31, diluted EPS contribution from the parent was $0.2535 on quarterly basis. For the annual period ended 2015-12-31, $0.26 was posted by Acorda Therapeutics, Inc. (NASDAQ:ACOR) as net basic EPS reading.

For the quarter ended 2015-12-31, basic net EPS of $0.26 was reported. The period ended 2015-12-31 had annual average basic shares outstanding of 42.23. But it was 42.23 for the quarter ended 2015-12-31. 43.621 and 43.621 were the diluted shares outstanding for the fiscal year ended is 2015-12-31 respectively.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 17 times, 1 visits today)